Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer

Oxidative Stress Clinical Trial

Official title:

Assessment of Thiol Disulfide Balance in Early Stage Endometrium Cancer

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04175067
• Other study ID #: 09/08/2018-13-9
• Status: Completed
• Start date: August 1, 2018
• Est. completion date: November 15, 2019

Study information

• Verified date: November 2019
• Source: Mugla Sitki Koçman University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to investigate thiol‑disulfide balance in early stage endometrium cancer patients.

Description:

To date various oxidative stress paramaters were studied in patients with endometrial cancer, however dynamic thiol disulfide hemostasis has not been previously investigated.

The thiol-disulfide balance in the circulation will be measured by the automated system created by Erel & Neselioglu(1).

References

1- Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 2014;47:326-32. doi:10.1016/j.clinbiochem.2014.09.026.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 117
• Est. completion date: November 15, 2019
• Est. primary completion date: October 31, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Histopathologically confirmed diagnosis of stage I endometrium cancer

Exclusion Criteria:

• pulmonary disease

• pulmonary hypertension

• cardiac dysfunction

• renal dysfunction

• liver disease

• chronic ishemia

• systemic inflammation

• concomitant malignancy

• patients who use vitamin A,C or E (antioxidant vitamins)

• patients who use smoke

• patients who use drink alcohol

• patients who use addictive for any drug

Related Conditions & MeSH terms

• Endometrial Neoplasms
• Endometrium Cancer
• Oxidative Stress

Intervention

Diagnostic Test:
• Disulphide(µmol/L)
Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with sphectrophotometry
• Total Oxidant Capacity(µmolH2O2Equiv/L)
Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with sphectrophotometry

Locations

Country	Name	City	State
Turkey	Mugla Sitki Kocman University Faculty of Medicine	Mugla

Sponsors (1)

Lead Sponsor	Collaborator
Mugla Sitki Koçman University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	serum native thiol level	serum native thiol level in µmol/L	preoperative in the morning or preprandial for healthy volunteers
Primary	serum disulphide level	serum disulphide level in µmol/L	preoperative in the morning or preprandial for healthy volunteers
Primary	serum total thiol level	serum total thiol level in µmol/L	preoperative in the morning or preprandial for healthy volunteers
Primary	the disulphide/native thiol ratio	the disulphide/native thiol ratio X (100 )	preoperative in the morning or preprandial for healthy volunteers
Primary	disulphide/total thiol ratio	disulphide/total thiol ratio X (100 )	preoperative in the morning or preprandial for healthy volunteers
Primary	native thiol/total thiol ratio	native thiol/total thiol ratio X (100 )	preoperative in the morning or preprandial for healthy volunteers
Secondary	total antioxidant capacity (TAC)	TAC in mmol trolox equivalent/L	preoperative in the morning or preprandial for healthy volunteers
Secondary	total oxidant capacity (TOC)	TOC in mmol H2O2 equivalent/L.	preoperative in the morning or preprandial for healthy volunteers
Secondary	Oxidative stress index (OSI)	OSI in mmol trolox/L.	preoperative in the morning or preprandial for healthy volunteers